Lippincotts Pharmaceuticals Private Limited, a active private limited company, was established on 08 March 2017 in Krishna, Andhra Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51909AP2017PTC105349. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Samba Siva Rao Vulleru (Director), Venkatasubbaiah Pujala (Director), Rajasekhar Reddy Devarapalli (Director). Past directors included Sreeramamohan Chabolu, Kakarla Pavan Kumar, Tumpala Mohana Deepthi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19-92/243, Shop No.243, 1St Floor, Mahatma Gandhi Wholesale Commercial Complex, Mahendra Nagar, Krishna, Andhra Pradesh, 521225.
U51909AP2017PTC105349
105349
08 March 2017
₹1.50 M
₹1.50 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Lippincotts Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samba Siva Rao Vulleru | Director | 06 Jul 2018 | Current |
| Venkatasubbaiah Pujala | Director | 29 Jun 2020 | Current |
| Rajasekhar Reddy Devarapalli | Director | 21 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Jun 2020 | Past |
| Pramod Abcsdd | Managing Director | 29 Jun 2020 | Past |
| Pramod Abcsdd | Director | 27 Jan 2018 | Past |
| Pramod Abcsdd | Director | 18 Aug 2017 | Past |
| Pramod Abcsdd | Managing Director | 06 Jul 2018 | Past |
| Pramod Abcsdd | Director | 30 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lippincotts Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.78% decrease. The company also saw a substantial improvement in profitability, with a 53.44% increase in profit. The company's net worth Soared by an impressive increase of 55.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Lippincotts Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lippincotts Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lippincotts Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lippincotts Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rajasekhar Reddy Devarapalli was appointed as a Director was appointed as a Director on 21 Oct 2024 & has been associated with this company since 1 year 2 months . was documented.
Lippincotts Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Lippincotts Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
Venkatasubbaiah Pujala was appointed as a Director was appointed as a Director on 29 Jun 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
Samba Siva Rao Vulleru was appointed as a Director was appointed as a Director on 06 Jul 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.
Progress on Lippincotts Pharmaceuticals Private Limited was registered on 08 Mar 2017 with Roc Vijayawada & aged 8 years 9 months as per MCA records. was documented.
The CIN of Lippincotts Pharmaceuticals Private Limited is U51909AP2017PTC105349.
Lippincotts Pharmaceuticals Private Limited is headquartered at 19-92/243, Shop No.243, 1St Floor, Mahatma Gandhi Wholesale Commercial Complex, Mahendra Nagar, Krishna, Andhra Pradesh, 521225.
Lippincotts Pharmaceuticals Private Limited was incorporated on 08 March 2017.
The current directors of Lippincotts Pharmaceuticals Private Limited are
The primary industry of Lippincotts Pharmaceuticals Private Limited is Pharma.
Lippincotts Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lippincotts Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Lippincotts Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX